IBIO Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
0
0
0
-100.0%
100.0K
-50.0%
200.0K
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
-100.0%
100.0K
-50.0%
200.0K
Operating Expenses
11.4M
+36.0%
8.4M
0
-100.0%
6.1M
+12.1%
5.4M
R&D
8.6M
+163.0%
3.3M
0
-100.0%
3.5M
+10.1%
3.2M
SG&A
-2182000
-142.7%
5.1M
0
-100.0%
2.5M
+15.0%
2.2M
Operating Income
-11380000
-36.0%
-8365000
0
+100.0%
-5951000
-14.5%
-5198000
EBITDA
-6225000
+24.2%
-8213000
0
+100.0%
-5823000
-14.8%
-5072000
Net Income
-10580000
-36.3%
-7761000
0
+100.0%
-5720000
-10.8%
-5163000
EPS (Basic)
$-0.04
+33.3%
$-0.06
$0.00
+100.0%
$-0.11
+69.4%
$-0.36
EPS (Diluted)
$-0.04
+33.3%
$-0.06
$0.00
+100.0%
$-0.11
+69.4%
$-0.36
Shares (Diluted)
243.7M
+103.7%
119.6M
0
-100.0%
53.0M
+268.7%
14.4M
iBio (IBIO) โ€” Financials